BluePath Capital Management’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Sell
7,742
-16
-0.2% -$3.17K 0.89% 26
2026
Q1
$1.28M Sell
7,758
-858
-10% -$149K 0.88% 33
2025
Q4
$1.53M Buy
8,616
+564
+7% +$94.1K 1.03% 18
2025
Q3
$1.28M Buy
8,052
+840
+12% +$124K 0.94% 29
2025
Q2
$1.02M Buy
7,212
+720
+11% +$88.4K 0.89% 33
2025
Q1
$757K Sell
6,492
-3,460
-35% -$446K 0.79% 39
2024
Q4
$1.23M Buy
9,952
+1,352
+16% +$167K 0.66% 33
2024
Q3
$896K Buy
8,600
+1,381
+19% +$139K 0.55% 46
2024
Q2
$702K Buy
7,219
+2,152
+42% +$205K 0.49% 58
2024
Q1
$477K Buy
5,067
+1,134
+29% +$99.9K 0.36% 72
2023
Q4
$360K Buy
3,933
+1,213
+45% +$97K 0.31% 76
2023
Q3
$222K Buy
+2,720
New +$236K 0.2% 89

Other funds holding MS

BluePath Capital Management's MS Position: Q2 2026 in Review

BluePath Capital Management reduced its Morgan Stanley (MS) stake by 0.21% in Q2 2026, selling an estimated $3.17K and leaving 7,742 shares worth $1.62M. The position accounts for 0.89% of the portfolio, ranked #26.

BluePath Capital Management first reported a position in MS in Q3 2023 and has held it in 12 quarters since. 863 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • BluePath Capital Management held 7,742 shares of Morgan Stanley worth $1.62M as of Q2 2026.
  • BluePath Capital Management sold 16 Morgan Stanley shares in Q2 2026, an estimated $3.17K.
  • Morgan Stanley made up 0.89% of BluePath Capital Management's portfolio in Q2 2026, its #26 holding.
  • BluePath Capital Management first reported a position in Morgan Stanley in Q3 2023 and has held it in 12 quarters since.
  • 863 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.